Language selection

Search

Details for: TARO-RISPERIDONE

Company: SUN PHARMA CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02328305TARO-RISPERIDONERISPERIDONE0.25 MGTABLETORAL
02328313TARO-RISPERIDONERISPERIDONE0.5 MGTABLETORAL
02328321TARO-RISPERIDONERISPERIDONE1 MGTABLETORAL
02328348TARO-RISPERIDONERISPERIDONE2 MGTABLETORAL
02328364TARO-RISPERIDONERISPERIDONE3 MGTABLETORAL
02328372TARO-RISPERIDONERISPERIDONE4 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: